Skip to main content
PMC home page
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2004 Nov 12;75(1):122–129. doi: 10.1002/jmv.20246

Laboratory diagnosis and surveillance of human respiratory viruses by PCR in Victoria, Australia, 2002–2003

Julian Druce 1, Thomas Tran 1, Heath Kelly 1, Matthew Kaye 1, Doris Chibo 1, Renata Kostecki 1, Abdul Amiri 1, Mike Catton 1, Chris Birch 1,✉
PMCID: PMC7166941  PMID: 15543580

Abstract

Respiratory viruses were identified by the polymerase chain reaction (PCR) in more than 4,200 specimens collected during 2002 and 2003 in Victoria, Australia from patients admitted to hospitals or participating in an influenza surveillance program. Influenza viruses and picornaviruses were important causes of morbidity in both years. Additional testing of picornavirus‐positive samples suggested that rhinoviruses but not enteroviruses were more likely to be associated with respiratory symptoms, irrespective of the season in which they circulated. Detection of influenza viruses was strongly associated with the clinical symptoms of cough, fever, and fatigue; but each of the other respiratory viruses occasionally caused these symptoms or was responsible for symptoms severe enough to require hospitalization. Human coronaviruses HCoV‐OC43 and HCoV‐229E circulated at low levels throughout the study period with peak activity in winter, but overall did not circulate as widely as has often been reported for these agents. Evidence for the human metapneumovirus (hMPV) was only sought in the second year of the study and revealed low‐level circulation of this virus, mainly in the cooler months among the very young and adult populations. The detection rate of all viruses declined with increasing age of the patient, particularly in hospital patients. Infection with more than one respiratory virus occurred in a small number of patients; picornaviruses were most commonly implicated in these dual infections. J. Med. Virol. 75:122–129, 2005. © 2005 Wiley‐Liss, Inc.

Keywords: nucleic acid detection, viruses causing respiratory symptoms, hospitalized patients, influenza surveillance

REFERENCES

  1. Allard A, Albinsson B, Wadell G. 1992. Detection of adenoviruses in stools from healthy persons and patients with diarrhoea by two‐step polymerase chain reaction. J Med Virol 37: 149–157. [DOI] [PubMed] [Google Scholar]
  2. Billaud G, Peny S, Kegay V, Lina B, Valette M. 2003. Detection of rhinovirus and enterovirus in upper respiratory tract samples using a multiplex nested PCR. J Virol Methods 108: 223–228. [DOI] [PubMed] [Google Scholar]
  3. Birch CJ, Clothier HJ, Seccall A, Tran T, Catton MC, Lambert SB, Druce JD. 2004. Human coronavirus OC43 causes influenza‐like illness in residents and staff of aged care facilities in Melbourne, Australia. Epidemiology and Infection (in press). [DOI] [PMC free article] [PubMed]
  4. Cianci C, Yu KL, Combrink K, Sin N, Pearce B, Wang A, Civiello R, Voss S, Luo G, Kadow K, Genovesi EV, Venables B, Gulgeze H, Trehan A, James J, Lamb L, Medina I, Roach J, Yang Z, Zadjura L, Colonno R, Clark J, Meanwell N, Krystal M. 2004. Orally active fusion inhibitor of respiratory syncytial virus. Antimicrob Agents Chemother 48: 413–422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cleland A, Nettleton P, Jarvis LM, Simmonds P. 1999. Use of bovine viral diarrhoea virus as an internal control for amplification of hepatitis C virus. Vox Sang 76: 170–174. [DOI] [PubMed] [Google Scholar]
  6. Cooper NJ, Sutton AJ, Abrams KR, Wailoo A, Turner DA, Nicholson KG. 2003. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: Systematic review and meta‐analysis of randomized controlled trials. BMJ 326: 1235–1242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Druce J, Catton M, Chibo D, Minerds K, Tyssen D, Kostecki R, Maskill B, Leong‐Shaw W, Gerrard M, Birch C. 2002. Utility of a multiplex PCR assay for detecting herpesvirus DNA in clinical samples. J Clin Microbiol 40: 1728–1732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Echavarria M, Sanchez JL, Kolavic‐Gray SA, Polyak CS, Mitchell‐Raymundo F, Innis BL, Vaughn D, Reynolds R, Binn LN. 2003. Rapid detection of adenovirus in throat swab specimens by PCR during respiratory disease outbreaks among military recruits. J Clin Microbiol 41: 810–812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Falsey AR, Walsh EE, Hayden FG. 2002. Rhinovirus and coronavirus infection‐associated hospitalizations among older adults. J Infect Dis 185: 1338–1341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Falsey AR, Erdman D, Anderson LJ, Walsh EE. 2003. Human metapneumovirus infections in young and elderly adults. J Infect Dis 187: 785–790. [DOI] [PubMed] [Google Scholar]
  11. Hall CB. 2001. Respiratory syncytial virus and parainfluenza virus. New Engl J Med 334: 1917–1927. [DOI] [PubMed] [Google Scholar]
  12. Hayden FG, Herrington DT, Coats TL, Kim K, Cooper EC, Villano SA, Liu S, Hudson S, Pevear DC, Collett M, McKinlay M. 2003. Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: Results of 2 double‐blind, randomized, placebo‐controlled trials. Clin Infect Dis 36: 1523–1532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ireland DC, Kent J, Nicholson KG. 1993. Improved detection of rhinoviruses in nasal throat swabs by seminested RT‐PCR. J Med Virol 40: 96–101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Johnston SL, Sanderson G, Pattemore PK, Smith S, Bardin PG, Bruce CB, Lambden PR, Tyrrell DA, Holgate ST. 1993. Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms. J Clin Microbiol 31: 111–117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lewis FA, Kennett ML. 1976. Comparison of rhinovirus‐sensitive HeLa cells and human embryo fibroblasts for isolation of rhinoviruses from patients with respiratory disease. J Clin Microbiol 3: 528–532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. McIntosh K. 1997. Coronaviruses In: Richman DD, Whitley RJ, Hayden FG, editors. Clinical virology. New York: Churchill Livingstone. [Google Scholar]
  17. McIntyre P, Gidding H, Gilmour R, Lawrence G, Hull B, Horby P, Wang H, Andrews R, Burgess M. 2002. Vaccine preventable diseases and vaccination coverage in Australia, 1999 to 2000. Comm Dis Intell Suppl i–xi: 22–25. [PubMed] [Google Scholar]
  18. Osiowy C. 1998. Direct detection of respiratory syncytial virus, parainfluenza virus, and adenovirus in clinical specimens by multiplex reverse transcription‐PCR assay. J Clin Microbiol 36: 3149–3154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Papadopoulos NG, Moustaki M, Tsolia M, Bossios A, Astra E, Prezerakou A, Gourgiotis D, Kafetzis D. 2002. Association of rhinovirus infection with increased disease severity in acute bronchitis. Am J Crit Care Med 165: 1285–1289. [DOI] [PubMed] [Google Scholar]
  20. Power UF, Nguyen TN, Rietveld E, de Swart RL, Groen J, Osterhaus AD, de Groot R, Corvaia N, Beck A, Bouvert‐Le‐Cam N, Bonnefoy JY. 2001. Safety and immunogenicity of a novel respiratory virus vaccine (BBG2Na) in healthy young adults. J Infect Dis 184: 1456–1460. [DOI] [PubMed] [Google Scholar]
  21. Steininger C, Aberle SW, Popow‐Kraupp T. 2001. Early detection of acute rhinovirus infections by a rapid reverse transcription‐PCR assay. J Clin Microbiol 39: 129–133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Uckun FM, Pendergrass S, Qazi S, Samuel P, Venkatachalam TK. 2004. Phenyl phosphoramidated derivatives of stavudine as anti‐HIV agents with potent and selective in vitro antiviral activity against adenovirus. Eur J Med Chem 39: 225–234. [DOI] [PubMed] [Google Scholar]
  23. Van den Hoogen BG, de Jong JC, Groen J, Kuiken T, de Groot R, Fouchier RA, Osterhaus AD. 2001. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 7: 719–724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. van der Hoek L, Pyrc K, Jebbink MF, Vermeulen‐Oost W, Berkhout RJM, Wolthers KC, Wertheim‐van Dillen PME, Kaandorp J, Spaargaren J, Berkhout B. 2004. Identification of a new coronavirus. Nat Med 10: 368–373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Vuorinen T, Vainionpaa R, Hyypia T. 2003. Five years' experience of reverse transcriptase polymerase chain reaction in daily diagnosis of enterovirus and rhinovirus infections. Clin Infect Dis 37: 452–455. [DOI] [PubMed] [Google Scholar]
  26. Watts CG, Andrews RM, Druce JD, Kelly HA. 2003. Establishing thresholds for influenza surveillance in Victoria. Aust NZ J Public Health 27: 409–412. [DOI] [PubMed] [Google Scholar]
  27. Zambon MC, Stockton JD, Clewley JP, Fleming DM. 2001. Contribution of influenza and respiratory syncytial virus to community cases of influenza‐like illness: An observational study. Lancet 358: 1410–1416. [DOI] [PubMed] [Google Scholar]
  28. Zhang W, Evans DH. 1991. PCR detection and differentiation of influenza virus A, B, and C strains. J Virol Methods 33: 165–189. [DOI] [PubMed] [Google Scholar]
  29. Zoll GJ, Melchers WJG, Kopecka H, Jambroes G, Van Der Poel HJA, Galama JMD. 1992. General primer‐mediated polymerase chain reaction for detection of enteroviruses: Application for diagnostic routine and persistent infections. J Clin Microbiol 30: 160–165. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Medical Virology are provided here courtesy of Wiley

RESOURCES